PT - JOURNAL ARTICLE AU - Ronja Mülfarth AU - Elisenda Alsina-Sanchis AU - Iris Moll AU - Sarah Böhn AU - Lena Wiedmann AU - Lorea Jordana AU - Tara Ziegelbauer AU - Jacqueline Taylor AU - Francesca De Angelis Rigotti AU - Adrian Stögbauer AU - Benedetto Daniele Giaimo AU - Adelheid Cerwenka AU - Tilman Borggrefe AU - Andreas Fischer AU - Juan Rodriguez-Vita TI - Endothelial Rbpj is essential for the education of tumour-associated macrophages AID - 10.1101/2021.12.20.473423 DP - 2022 Jan 01 TA - bioRxiv PG - 2021.12.20.473423 4099 - http://biorxiv.org/content/early/2022/05/23/2021.12.20.473423.short 4100 - http://biorxiv.org/content/early/2022/05/23/2021.12.20.473423.full AB - Epithelial ovarian cancer (EOC) is one of the most lethal gynaecological cancers worldwide. EOC cells educate tumour-associated macrophages (TAMs) through CD44-mediated cholesterol depletion to generate an immunosuppressive tumour microenvironment (TME). In addition, tumour cells frequently activate Notch1 receptors on endothelial cells (ECs) to facilitate metastasis. However, little is known whether the endothelium would also influence the education of recruited monocytes. Here, we report that canonical Notch signalling through RBPJ in ECs is an important player in the education of TAMs and EOC progression. Deletion of Rbpj in the endothelium of adult mice reduced infiltration of monocyte-derived macrophages into the TME of EOC and prevented the acquisition of a typical TAM gene signature. This was associated with stronger cytotoxic activity of T cells and decreased tumour burden. Mechanistically, we identified CXCL2 as a novel Notch/RBPJ target gene. This angiocrine factor regulates the expression of CD44 on monocytes and subsequent cholesterol depletion of TAMs. Bioinformatic analysis of ovarian cancer patient data showed that increased CXCL2 expression is accompanied by higher expression of CD44 and TAM education. As such, EOC cells employ the tumour endothelium to secrete CXCL2 in order to facilitate an immunosuppressive microenvironment.Competing Interest StatementThe authors have declared no competing interest.